New therapies, new concerns: rituximab-associated lung injury.
Lands
Larry C
LC
D000818:Animals; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents / Q000009:adverse effects*; D006801:Humans; D055370:Lung Injury / Q000139:chemically induced* / Q000473:pathology / Q000628:therapy; D000069283:Rituximab
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents; D000069283:Rituximab